Cargando…

Autologous transplant and second malignancies in MM

Detalles Bibliográficos
Autores principales:	Pasvolsky, Oren, Bashir, Qaiser
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Hematology 2023
Materias:	Inside Blood Advances
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10333739/ https://www.ncbi.nlm.nih.gov/pubmed/37318936 http://dx.doi.org/10.1182/bloodadvances.2023010051

Ejemplares similares

Small but mighty: T-replete cords for myeloid disease
por: LaBelle, James L.
Publicado: (2023)

The sweet taste of liberalizing dietary restrictions in HCT
por: Peled, Jonathan U., et al.
Publicado: (2023)

Further evidence supporting the global use of hydroxyurea
por: Archer, Natasha M.
Publicado: (2023)

Blood stem cell grafts: frozen is fine, but fresh is best
por: Horwitz, Mitchell E.
Publicado: (2023)

More evidence for low-dose IL-2 for chronic GVHD in children
por: Levine, John E.
Publicado: (2023)

Diagnosing TMAs by automated red cell morphology analyses
por: Billett, Henny H., et al.
Publicado: (2023)

Peripheral megakaryocytes sound the alarm in COVID-19
por: Boilard, Eric, et al.
Publicado: (2023)

This CAR won’t start: predicting nonresponse in ALL
por: Webster, Jonathan A., et al.
Publicado: (2023)

Haplo ever after: haplo PTCy for children
por: Talano, Julie-An, et al.
Publicado: (2023)

Histidine-rich glycoprotein: antithrombosis without bleeding
por: Schmaier, Alvin H.
Publicado: (2023)

Natalizumab for GVHD: too little or too late?
por: Quann, Kevin, et al.
Publicado: (2023)

ADP: the missing link between thrombosis and hemolysis
por: Gerber, Gloria F., et al.
Publicado: (2023)

A wholesale approach to disarm multiple myeloma
por: Cenci, Simone
Publicado: (2023)

It’s high time to turn the spotlight on HbSC disease
por: Oluwole, Olubusola, et al.
Publicado: (2023)

On a collision course: SARS-CoV-2 variants and CAR T cells
por: Auletta, Jeffery J.
Publicado: (2023)

Comorbidities in DLBCL: too "Severe4" CAR-T therapy?
por: Qualls, David, et al.
Publicado: (2023)

ICANS prophylaxis: potentially transformative but elusive
por: Dowling, Mark R., et al.
Publicado: (2023)

Cord blood power and the definition of success after BMT
por: Boelens, Jaap Jan, et al.
Publicado: (2022)

Curing CLL: one clone at a time
por: Aslan, Burcu, et al.
Publicado: (2022)

HTLV-1 infection: role of CTL efficiency
por: Bangham, Charles R. M.
Publicado: (2008)

On the Inside
por: Minorsky, Peter V.
Publicado: (2021)

On the inside
por: Minorsky, Peter V
Publicado: (2021)

On the Inside
por: Minorsky, Peter V
Publicado: (2021)

On the Inside
por: Minorsky, Peter V
Publicado: (2021)

A Prospective Trial Comparing Haploidentical Donor Transplantation With Cord Blood Versus HLA-Matched Sibling Donor Transplantation for Hematologic Malignancy Patients
por: Lu, Wenyi, et al.
Publicado: (2022)

The management of venous thromboembolism in hospitalized patients with COVID-19
por: Spyropoulos, Alex C.
Publicado: (2020)

COVID-19 coagulopathy vs disseminated intravascular coagulation
por: Levi, Marcel
Publicado: (2020)

GRNDaD: big data and sickle cell disease
por: Lanzkron, Sophie, et al.
Publicado: (2022)

Why is AAV FVIII gene therapy not approved by the US Food and Drug Administration yet?
por: Arruda, Valder R.
Publicado: (2021)

Investigational curative gene therapy approaches to sickle cell disease
por: Williams, David A., et al.
Publicado: (2021)

Autologous cord blood cell infusion in preterm neonates safely reduces respiratory support duration and potentially preterm complications
por: Ren, Zhuxiao, et al.
Publicado: (2019)

Risk of hematological malignancy in blood donors: A nationwide cohort study
por: Zhao, Jingcheng, et al.
Publicado: (2020)

White Matter Tract Changes Associated with Clinical Improvement in an Open‐Label Trial Assessing Autologous Umbilical Cord Blood for Treatment of Young Children with Autism
por: Carpenter, Kimberly L. H., et al.
Publicado: (2019)

COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA
por: Pagano, Livio, et al.
Publicado: (2022)

SECOND MALIGNANCIES AFTER AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION IN CHILDREN
por: Danner-Koptik, Karina E, et al.
Publicado: (2012)

Efficacy of tixagevimab-cilgavimab in preventing SARS-CoV-2 for patients with B-cell malignancies
por: Davis, James A., et al.
Publicado: (2023)

House calls for stem cell transplant patients during the COVID-19 pandemic
por: Sung, Anthony D., et al.
Publicado: (2020)

Cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia after a second ChAdOx1 nCoV-19 dose
por: Krzywicka, Katarzyna, et al.
Publicado: (2022)

Unrelated Donor Cord Blood Transplantation in Children: Lessons Learned Over 3 Decades
por: Kurtzberg, Joanne, et al.
Publicado: (2023)

Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR T-cell therapy
por: Dhakal, Binod, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_u8d1h2ejg0a4pm01425laqbbtk